Lisinopril Tablets, USP, 5 mg, Rx Only, 1000-count bottle, Manufactured for: Lupin Pharmaceutical...

FDA Recall #D-1290-2020 — Class II — May 28, 2020

Recall #D-1290-2020 Date: May 28, 2020 Classification: Class II Status: Terminated

Product Description

Lisinopril Tablets, USP, 5 mg, Rx Only, 1000-count bottle, Manufactured for: Lupin Pharmaceuticals Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Nagpur - 441 108, India, NDC 68180-513-03.

Reason for Recall

Product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg 1000-count bottle.

Recalling Firm

Lupin Pharmaceuticals Inc. — Baltimore, MD

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

4,224 bottles

Distribution

Nationwide within the US.

Code Information

Lot # Q900683, Exp. 10/31/2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated